Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9V3Z

SLC36A1 bound to D-NPA

This is a non-PDB format compatible entry.
Summary for 9V3Z
Entry DOI10.2210/pdb9v3z/pdb
EMDB information64762
DescriptorProton-coupled amino acid transporter 1, 2-acetamido-2-deoxy-beta-D-glucopyranose, (3S)-piperidine-3-carboxylic acid (3 entities in total)
Functional Keywordslysosomal membrane protein npa, transport protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight53462.60
Authors
Zhang, S.S. (deposition date: 2025-05-22, release date: 2026-07-29)
Primary citationYin, J.,Zhang, S.,Liu, C.,Xie, M.,Gao, Y.,Chen, M.,Wang, Y.,Chen, M.,Fan, H.,Yang, Z.,Li, H.,Liang, L.,Zhou, B.,Chen, X.,Yang, M.
Substrate recognition and transport mechanism of the human proton-coupled amino-acid transporter 1 (SLC36A1).
Nat Commun, 2026
Cited by
PubMed Abstract: The proton-coupled amino-acid transporter SLC36A1 (hPAT1) is an atypical H⁺-driven carrier and mediates the intestinal absorption of a wide array of zwitterionic amino-acid analogs, including many compounds with central nervous-system (CNS) activity, as well as the activation of the mTORC1 pathway and the export of amino acids from lysosomes, thereby maintaining cellular amino-acid homeostasis. Here, we present the cryo-EM structures of a member of the SLC36 family, hPAT1, in its apo state and in complex with three chemically distinct substrates, including the α-amino acid D-serine, the β-amino acid nipecotic acid, and the heterocyclic drug D-cycloserine, at resolutions of 3.4-3.5 Å. Despite their chemical diversity, all ligands adopt a spatially convergent binding mode, elucidating the structural basis for PAT1's broad substrate promiscuity. In addition, we identify E270 as a potential proton-binding site. Together, these findings provide structural insights into the molecular mechanism of proton-coupled amino acid transport. Notably, the cryo-EM structure of PAT1 bound to D-cycloserine illustrates a viable oral CNS drug delivery strategy: exploiting polar scaffolds to achieve transporter-mediated intestinal absorption and blood-brain barrier penetration without relying on high lipophilicity.
PubMed: 42414312
DOI: 10.1038/s41467-026-75306-z
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.4 Å)
Structure validation

257179

PDB entries from 2026-07-29

PDB statisticsPDBj update infoContact PDBjnumon